Pharmacokinetic and pharmacodynamic profile of the sodium‐glucose co‐transporter‐2 inhibitor empagliflozin in young people with Type 2 diabetes: a randomized trial
Sign Up to like & getrecommendations! Published in 2018 at "Diabetic Medicine"
DOI: 10.1111/dme.13629
Abstract: To assess the pharmacokinetic and pharmacodynamic profile of a single dose of empagliflozin in young people with Type 2 diabetes to identify the appropriate doses for further paediatric development. read more here.
Keywords: pharmacodynamic profile; people type; empagliflozin young; type diabetes ... See more keywords